HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lanvin restructuring

This article was originally published in The Rose Sheet

Executive Summary

Faced with "a deteriorated economic situation," French company announces plan to license its fragrance business in an effort to focus on its core luxury ready-to-wear collections for men and women. Restructuring program is aimed at reducing costs 25%, and will also include the elimination of 65 jobs and Lanvin's watchmaking business. In 2003, the company posted a net loss of $26.8 mil. (€1=$1.21). Lanvin fashion and fragrance brand was purchased from L'Oréal by Taiwanese investor Shaw-Lan Wang and a group of private French investors in 2001...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012038

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel